TG Therapeutics, Inc. (TGTX)

TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,532	4,320	2,416	1,584	2,488	6,703
Market Cap Growth	16.49%	78.80%	52.51%	-36.33%	-62.88%	515.51%
Enterprise Value	4,655	4,233	2,297	1,491	2,159	6,490
Last Close Price	31.00	30.10	17.08	11.83	19.00	52.02
PE Ratio	11.17	184.75	190.66	-	-	-
Forward PE	20.79	45.21	-	-	-	-
PS Ratio	8.51	13.13	10.34	568.84	371.96	44096.70
PB Ratio	7.28	19.43	15.05	27.04	10.49	12.91
P/TBV Ratio	7.46	19.43	15.05	27.41	10.53	12.93
EV/Sales Ratio	8.75	12.87	9.83	535.24	322.82	42698.06
EV/EBITDA Ratio	45.27	100.79	110.20	-	-	-
EV/EBIT Ratio	45.29	100.95	111.33	-	-	-
Debt / Equity Ratio	0.42	1.14	0.69	1.42	0.34	0.08
Debt / EBITDA Ratio	2.43	5.74	4.82	-	-	-
Asset Turnover	0.66	0.73	0.89	0.01	0.01	0
Inventory Turnover	0.67	0.51	-	-	-	-
Quick Ratio	2.53	4.85	5.00	3.04	4.84	6.92
Current Ratio	3.83	6.25	5.92	3.16	5.06	6.99
Return on Equity (ROE)	111.96%	12.21%	11.57%	-151.36%	-92.03%	-100.14%
Return on Assets (ROA)	7.98%	5.78%	4.93%	-47.61%	-42.87%	-43.36%
Return on Capital (ROIC)	9.82%	7.00%	6.24%	-59.52%	-49.04%	-53.28%
Return on Capital Employed (ROCE)	11.80%	8.60%	7.50%	-	-	-
Earnings Yield	9.87%	0.54%	0.52%	-14.13%	-13.99%	-4.17%
FCF Yield	-1.55%	-0.94%	-1.30%	-11.12%	-11.90%	-3.21%
Buyback Yield / Dilution	-11.64%	-7.96%	-9.67%	-2.41%	-14.64%	-30.51%

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q